Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.

Helicobacter pylori (H pylori), a common bacteria that can infect the stomach, has been linked to more than one in five bowel ...

Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the ...

The AV dosing was vornoprazan 20mg twice daily and amoxicillin 750mg four times daily; BAV addedtripotassium dicitrato ...

Drinking at least one sugar-sweetened beverage daily was associated with 2.45 times the risk of stomach cancer. The findings ...

Onconic Therapeutics won approval for a Phase 3 trial of Jaqbo in Helicobacter pylori eradication therapy, enrolling 414 ...

About 43.9% of South Korean adults test positive for H. pylori, but guidelines recommend eradication therapy only for ...

Oita University is helping Bhutan tackle gastric cancer by supporting local production of rapid tests for Helicobacter pylori ...

A new study published in the Journal of American Medical Association showed that despite partial participant adherence, it was more cost-effective to invite people to undertake combined Helicobacter ...

From a US perspective, higher healthcare costs precluded cost savings, yet co-testing remained cost-effective in 99.6% of simulations at base-case prevalence. In this pragmatic, real-world evaluation ...

Why do municipalities subsidize H. pylori testing? Did you know the shocking fact that approximately 95% of stomach cancer cases are linked to H. pylori infection? This is not just one risk factor; it ...

There are trillions of bacteria in the human digestive tract. In the mouth, bacteria help initiate the breakdown of food. In the intestines, they process complex molecules into nutrients that human ...